Demographic and clinical findings:
In total, 60 (53%) patients were women and 53 (47%) men. The mean age of the participants was 3.6 ± 1.2 years (range: 3 months to 18 years). Thirty (26.5%) patients had a body weight below the 10th percentile for age. Moreover, 93 (82.3%) were diagnosed with CAP and 18 (15.9%) with CCAP. There was no significant difference in sex between the two groups. In total, 15 (13%) patients had a history of previous CAP. Further, during admission, 105 (92.9%) had cough; 91 (80.5%), fever; and 8 (7.07%), chest pain. Then, 43 (38.05%) patients received peroral antibiotic–antiviral therapy (n=12, amoxicillin–clavulanic acid; n=8, cephalosporins; n=14, macrolides; n=7, amoxicillin–clavulanic and macrolides; and n=2, oseltamivir) before admission. Antibiotic use before admission and history of pneumonia did not significantly differ between the CAP and CCAP groups (p=0.250, 0.223, 0.324, 0.659, 0.253, and 0.546, respectively). The average CCAP patients’ age was 4.2±3.3 years. The age of CAP patients was greater than the mean age (2.8±2.1 years) (p=0.012). In our study, none of the patients presented with severe malnutrition. Although patients diagnosed with CCAP commonly have a body weight below the 10th percentile for age, the 2 groups did not significantly differ (p=0.024). Respiratory distress (tachypnea and retraction) and hypoxia (SaO2 <92%) were significantly more common in patients diagnosed with CCAP at presentation than in those diagnosed with CAP (p<0.001 and<0.001, respectively) (Table-1). None of the CAP and CCAP patients died due to local and systemic complications during hospitalization (Table-1).